Thorsten Berg - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Thorsten Berg

Showing results (71-80 of 76) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 76 results.

Angewandte Chemie (International Ed. in English)|March 17, 2023

Morphological Profiling Identifies the Motor Protein Eg5 as Cellular Target of SpirooxindolesJie Liu, Shubhadip Mallick, Yusheng Xie, et al.

Frontiers in Immunology|November 3, 2023

GM-CSF-activated STAT5A regulates macrophage functions and inflammation in atherosclerosisJan Nagenborg, Han Jin, Adele V Ruder, et al.

Chembiochem : a European Journal of Chemical Biology|January 5, 2023

Nutlin-3a-aa: Improving the Bioactivity of a p53/MDM2 Interaction Inhibitor by Introducing a Solvent-Exposed Methylene GroupFlorian Nietzold, Stefan Rubner, Beata Labuzek, et al.

Angewandte Chemie (International Ed. in English)|April 16, 2010

A scaffold-tree-merging strategy for prospective bioactivity annotation of gamma-pyronesStefan Wetzel, Wolfram Wilk, Samy Chammaa, et al.

Molecular Cancer Therapeutics|October 5, 2010

The quassinoid derivative NBT-272 targets both the AKT and ERK signaling pathways in embryonal tumorsDeborah Castelletti, Giulio Fiaschetti, Valeria Di Dato, et al.

Blood|May 31, 2012

FGF-2 expands murine hematopoietic stem and progenitor cells via proliferation of stromal cells, c-Kit activation, and CXCL12 down-regulationTomer Itkin, Aya Ludin, Ben Gradus, et al.

Pageof 8

Search research articles

Showing results (71-80 of 76) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 76 results.

Angewandte Chemie (International Ed. in English)|March 17, 2023

Morphological Profiling Identifies the Motor Protein Eg5 as Cellular Target of SpirooxindolesJie Liu, Shubhadip Mallick, Yusheng Xie, et al.

Frontiers in Immunology|November 3, 2023

GM-CSF-activated STAT5A regulates macrophage functions and inflammation in atherosclerosisJan Nagenborg, Han Jin, Adele V Ruder, et al.

Chembiochem : a European Journal of Chemical Biology|January 5, 2023

Nutlin-3a-aa: Improving the Bioactivity of a p53/MDM2 Interaction Inhibitor by Introducing a Solvent-Exposed Methylene GroupFlorian Nietzold, Stefan Rubner, Beata Labuzek, et al.

Angewandte Chemie (International Ed. in English)|April 16, 2010

A scaffold-tree-merging strategy for prospective bioactivity annotation of gamma-pyronesStefan Wetzel, Wolfram Wilk, Samy Chammaa, et al.

Molecular Cancer Therapeutics|October 5, 2010

The quassinoid derivative NBT-272 targets both the AKT and ERK signaling pathways in embryonal tumorsDeborah Castelletti, Giulio Fiaschetti, Valeria Di Dato, et al.

Blood|May 31, 2012

FGF-2 expands murine hematopoietic stem and progenitor cells via proliferation of stromal cells, c-Kit activation, and CXCL12 down-regulationTomer Itkin, Aya Ludin, Ben Gradus, et al.

Pageof 8